Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2025)

Tarsus Pharmaceuticals (TARS) has 5 years of Asset Utilization Ratio data on record, last reported at 0.82 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 69.45% year-over-year to 0.82; the TTM value through Dec 2025 reached 0.82, up 69.45%, while the annual FY2025 figure was 0.96, 68.78% up from the prior year.
  • Asset Utilization Ratio reached 0.82 in Q4 2025 per TARS's latest filing, up from 0.71 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.82 in Q4 2025 and bottomed at 0.06 in Q2 2023.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.26 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: decreased 22.0% in 2023, then surged 643.11% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.31 in 2021, then plummeted by 74.06% to 0.08 in 2022, then dropped by 18.39% to 0.07 in 2023, then soared by 643.11% to 0.49 in 2024, then soared by 69.45% to 0.82 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.82 in Q4 2025, 0.71 in Q3 2025, and 0.59 in Q2 2025.